Mechanisms of illness progression in the recurrent affective disorders.
Along with genetic vulnerability, multiple environmental factors convey liability to illness progression, including: (1) distal and proximal stressors; (2) recurrence of episodes; and (3) comorbid cocaine abuse. Recurrence of each of these can increase responsivity (sensitize) to themselves and cross-sensitize to the two other factors and drive illness progression as seen clinically in increases in cycle acceleration, severity or duration of episodes, treatment refractoriness, disability, cognitive dysfunction, and premature death. Some mechanisms appear common to all three types of sensitization, such as decreases of brain-derived neuroprotective factor (BDNF) in hippocampus and blood, as well as increases in BDNF in the nucleus accumbens, suggesting the possibility that single treatments could ameliorate several of these factors at once. A potential example is N-acetylcysteine (NAC), which decreases bipolar affective illness severity (Berk et al. Biol Psychiatry 64:468–475, 2008) and cocaine reinstatement and craving (Baker et al. Ann N Y Acad Sci 1003:349–351, 2003; LaRowe et al. Am J Addict 15:105–110, 2006). Mechanisms of illness progression also involve epigenetic changes and add further rationale to the existing empirical clinical evidence of the importance of early recognition, treatment, and prevention of affective episodes. Adequate treatment could prevent or ameliorate both the increases in pathological factors and erosion of adaptive factors that propel illness exacerbation and treatment resistance. This view of the sensitization and cross-sensitization among stressors, episodes, and abused substances should lead to a fundamental re-conceptualization of the recurrent affective disorders not as benign, isolated episodes of “mental” illness, but as severe, potentially progressive and lethal medical disorders of brain and body that deserve careful life-long monitoring and treatment.
Post
Robert M
RM
Bipolar Collaborative Network, 5415 W. Cedar Lane, Suite 201-B, Bethesda, MD 20814, USA. robert.post@speakeasy.net
D000818:Animals; D019970:Cocaine-Related Disorders / Q000150:complications / Q000523:psychology; D018450:Disease Progression; D006801:Humans; D019964:Mood Disorders / Q000209:etiology* / Q000517:prevention & control / Q000523:psychology*; D055502:Secondary Prevention; D012931:Social Environment; D013315:Stress, Psychological / Q000150:complications / Q000523:psychology
Am J Addict. 2006 Jan-Feb;15(1):105-10
16449100
Biol Psychiatry. 1998 Aug 1;44(3):193-206
9693391
Biol Psychiatry. 2009 May 1;65(9):760-9
19150054
Bipolar Disord. 2009 Nov;11(7):744-52
19719787
Biol Psychiatry. 2004 May 1;55(9):875-81
15110730
Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
4110397
Biol Psychiatry. 2000 Jul 1;48(1):1-8
10913502
Br J Psychiatry. 1998 Jan;172:23-8
9534827
JAMA. 2007 Oct 17;298(15):1794-6
17940236
Psychiatry Res. 2008 Oct 30;164(1):30-47
18801648
Biol Psychiatry. 2008 Sep 15;64(6):468-75
18534556
Biol Psychiatry. 2006 Jun 15;59(12):1151-9
16566899
Science. 2006 Feb 10;311(5762):864-8
16469931
Am J Psychiatry. 2003 Aug;160(8):1516-8
12900317
Am J Psychiatry. 2001 Apr;158(4):582-6
11282692
J Affect Disord. 2007 Dec;104(1-3):91-5
17434599
J Nerv Ment Dis. 1994 Jun;182(6):349-52
8201307
Nat Neurosci. 2007 Sep;10(9):1089-93
17726474
Mol Neurobiol. 1996 Aug;13(1):33-60
8892335
Expert Rev Neurother. 2008 Jul;8(7):1101-13
18590480
J Psychiatry Neurosci. 2009 Jul;34(4):263-71
19568477
J Psychiatr Res. 2007 Dec;41(12):979-90
17239400
Ann Clin Psychiatry. 2003 Jun;15(2):85-94
12938866
Neurosci Biobehav Rev. 2008;32(4):675-92
18199480
J Affect Disord. 2008 Dec;111(2-3):135-44
18539338
Biol Psychiatry. 2007 Oct 15;62(8):894-900
17617385
J Clin Psychiatry. 2010 Jul;71(7):864-72
20667291
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19186-91
16380431
J Clin Psychiatry. 2006 Jan;67(1):115-25
16426098
J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1662-6
15548477
Learn Mem. 2007 Apr 06;14(4):268-76
17522015
Neuron. 2005 Oct 20;48(2):303-14
16242410
Biol Psychiatry. 2006 Jun 15;59(12):1116-27
16631126
Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):223-44
1665095
Br J Psychiatry. 2008 Apr;192(4):290-3
18378992
Brain Res Mol Brain Res. 1991 Aug;11(1):55-64
1662746
Biol Psychiatry. 2004 Apr 1;55(7):708-14
15038999
Bipolar Disord. 2006 Apr;8(2):103-16
16542180
Eur Arch Psychiatry Clin Neurosci. 1999;249(5):227-30
10591987
Exp Neurol. 1969 Nov;25(3):295-330
4981856
Nat Neurosci. 2005 Nov;8(11):1445-9
16251986
Biol Psychiatry. 1992 Sep 15;32(6):469-84
1445965
Exp Neurol. 2005 Apr;192(2):235-43
15755541
J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1380-6
15502597
Nat Rev Neurosci. 2007 May;8(5):355-67
17453016
J Psychiatr Res. 2009 Jan;43(3):274-81
18656896
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3480-5
16484373
Curr Psychiatry Rep. 2005 Dec;7(6):413-20
16318818
Ann N Y Acad Sci. 2003 Nov;1003:349-51
14684458
Biol Psychiatry. 2003 Nov 15;54(10):1025-34
14625144
Acta Psychiatr Scand Suppl. 2007;(434):17-26
17688459
Sci Am. 1987 Jun;256(6):80-9
3589645
Neuropsychopharmacology. 2008 Jan;33(1):166-80
17805308
Int J Neuropsychopharmacol. 2009 May;12(4):447-58
18771602
Brain Res Brain Res Rev. 1995 Mar;20(3):305-25
7550363
Bipolar Disord. 2007 Jun;9 Suppl 1:128-35
17543031
Biol Psychiatry. 2006 Jun 15;59(12):1227-35
16457784
Prev Chronic Dis. 2006 Apr;3(2):A42
16539783
Brain Res Mol Brain Res. 1992 Oct;15(3-4):247-55
1359374
Pharmacol Biochem Behav. 1983 Jan;18(1):61-3
6828538
Am J Psychiatry. 1992 Aug;149(8):999-1010
1353322
Neurosci Biobehav Rev. 2007;31(6):858-73
17555817
Life Sci. 1975 Sep 15;17(6):943-50
1238889
J Affect Disord. 2006 Jul;93(1-3):105-15
16677713
Nat Neurosci. 2006 Apr;9(4):519-25
16501568
Neurotox Res. 2008 Oct;14(2-3):185-9
19073425
Am J Psychiatry. 2001 Mar;158(3):420-6
11229983
Biol Psychiatry. 2007 Jul 1;62(1):7-16
17240360
Arch Gen Psychiatry. 2008 Nov;65(11):1331-5
18981345
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6406-11
17379666
Am J Psychiatry. 2000 Aug;157(8):1243-51
10910786
J Pediatr. 2007 May;150(5):485-90
17452221
J Affect Disord. 2006 Oct;95(1-3):43-9
16837055
Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76
18205981
Am J Psychiatry. 2005 Aug;162(8):1403-13
16055761
Biol Psychiatry. 2008 Feb 1;63(3):338-40
17719565
Biol Psychiatry. 2008 Aug 15;64(4):336-43
18468583